Ignite Creation Date:
2025-12-25 @ 12:21 AM
Ignite Modification Date:
2026-01-04 @ 4:40 AM
Study NCT ID:
NCT05225558
Status:
TERMINATED
Last Update Posted:
2025-05-06
First Post:
2022-01-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2a Study, Effect of Vancomycin With vs Without Delpazolid (LCB01-0371) in Patients With MRSA Bacteremia
Sponsor:
LigaChem Biosciences, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-26
Start Date Type:
ACTUAL
Primary Completion Date:
2024-02-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-03-18
Completion Date Type:
ACTUAL
First Submit Date:
2022-01-26
First Submit QC Date:
None
Study First Post Date:
2022-02-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-01-09
Results First Submit QC Date:
None
Results First Post Date:
2025-05-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-17
Last Update Post Date:
2025-05-06
Last Update Post Date Type:
ACTUAL